248 related articles for article (PubMed ID: 26857235)
1. Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells.
Villa NY; Bais S; Chan WM; Meacham AM; Wise E; Rahman MM; Moreb JS; Rosenau EH; Wingard JR; McFadden G; Cogle CR
Cytotherapy; 2016 Mar; 18(3):465-80. PubMed ID: 26857235
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro.
Madlambayan GJ; Bartee E; Kim M; Rahman MM; Meacham A; Scott EW; McFadden G; Cogle CR
Leuk Res; 2012 May; 36(5):619-24. PubMed ID: 22341701
[TBL] [Abstract][Full Text] [Related]
3. Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.
Srour EF; Bregni M; Traycoff CM; Agüero B; Kosak ST; Hoffman R; Siena S; Gianni AM
Blood Cells Mol Dis; 1996; 22(1):68-81. PubMed ID: 8807087
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.
Rahman MM; Madlambayan GJ; Cogle CR; McFadden G
Cytokine Growth Factor Rev; 2010; 21(2-3):169-75. PubMed ID: 20211576
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of autologous bone marrow pre-loaded
Villa NY; Rahman MM; Mamola J; Sharik ME; de Matos AL; Kilbourne J; Lowe K; Daggett-Vondras J; D'Isabella J; Goras E; Chesi M; Bergsagel PL; McFadden G
Oncotarget; 2022; 13():490-504. PubMed ID: 35251496
[TBL] [Abstract][Full Text] [Related]
6. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
7. Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells.
Breems DA; Blokland EA; Siebel KE; Mayen AE; Engels LJ; Ploemacher RE
Blood; 1998 Jan; 91(1):111-7. PubMed ID: 9414274
[TBL] [Abstract][Full Text] [Related]
8. Ex Vivo Virotherapy with Myxoma Virus to Treat Cancer.
Villa NY; Franco LS; McFadden G
Methods Mol Biol; 2020; 2058():95-110. PubMed ID: 31486033
[TBL] [Abstract][Full Text] [Related]
9. Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells.
Villa NY; Wasserfall CH; Meacham AM; Wise E; Chan W; Wingard JR; McFadden G; Cogle CR
Blood; 2015 Jun; 125(24):3778-88. PubMed ID: 25904246
[TBL] [Abstract][Full Text] [Related]
10. A stromal-free, serum-free system to expand ex vivo hematopoietic stem cells from mobilized peripheral blood of patients with hematologic malignancies and healthy donors.
Yao CL; Hsu SC; Hwang SM; Lee WC; Chiou TJ
Cytotherapy; 2013 Sep; 15(9):1126-35. PubMed ID: 23768928
[TBL] [Abstract][Full Text] [Related]
11. A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia.
Maciejewski JP; Selleri C; Sato T; Anderson S; Young NS
Blood; 1996 Sep; 88(6):1983-91. PubMed ID: 8822917
[TBL] [Abstract][Full Text] [Related]
12. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[TBL] [Abstract][Full Text] [Related]
13. Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123.
Leemhuis T; Yoder MC; Grigsby S; Agüero B; Eder P; Srour EF
Exp Hematol; 1996 Aug; 24(10):1215-24. PubMed ID: 8765497
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
[TBL] [Abstract][Full Text] [Related]
15. Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus.
Bartee E; Chan WM; Moreb JS; Cogle CR; McFadden G
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1540-51. PubMed ID: 22516053
[TBL] [Abstract][Full Text] [Related]
16. Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin.
Zemp FJ; Lun X; McKenzie BA; Zhou H; Maxwell L; Sun B; Kelly JJ; Stechishin O; Luchman A; Weiss S; Cairncross JG; Hamilton MG; Rabinovich BA; Rahman MM; Mohamed MR; Smallwood S; Senger DL; Bell J; McFadden G; Forsyth PA
Neuro Oncol; 2013 Jul; 15(7):904-20. PubMed ID: 23585629
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
[TBL] [Abstract][Full Text] [Related]
18. Fate of contaminating t(14; 18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cells.
Widmer L; Pichert G; Jost LM; Stahel RA
Blood; 1996 Oct; 88(8):3166-75. PubMed ID: 8874217
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
[TBL] [Abstract][Full Text] [Related]
20. CD34+CDw90(Thy-1)+ subset colocated with mesenchymal progenitors in human normal bone marrow hematon units is enriched in colony-forming unit megakaryocytes and long-term culture-initiating cells.
Boiret N; Rapatel C; Boisgard S; Charrier S; Tchirkov A; Bresson C; Camilleri L; Berger J; Guillouard L; Guérin JJ; Pigeon P; Chassagne J; Berger MG
Exp Hematol; 2003 Dec; 31(12):1275-83. PubMed ID: 14662335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
